ASSERTIO THERAPEUTICS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-12-09: Reporting owner BURRILL STEVEN; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-12-09: Reporting owner DAWES KAREN A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-12-09: Reporting owner Schoeneck James A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-12-09: Reporting owner SMITH CRAIG R; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-12-09 | BURRILL STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | DAWES KAREN A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | Schoeneck James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | SMITH CRAIG R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | STAPLE PETER D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | STERN JULIAN N Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-12-09 | Zenoff David B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.60 exercise price | 2010-12-13 | |
| 2010-01-07 | Gosling Matthew M Officer (VP, General Counsel) | 4 | Stock option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $3.09 exercise price | 2010-01-08 | |
| 2010-01-07 | Sweeney Michael MD Officer (VP, Research & Development) | 4 | Stock option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,000 85,000 owned after | $3.09 exercise price | 2010-01-08 | |
| 2010-01-07 | Cameron Tammy Officer (VP, Finance) | 4 | Stock option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $3.09 exercise price | 2010-01-08 | |
| 2010-01-07 | Pelzel Carl A Director, Officer (President and CEO) | 4 | Stock option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $3.09 exercise price | 2010-01-08 |